Skip to content
Back to NKTR

Nektar Therapeutics

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
16
Purchases
0
Sales
16
Purchase value
$0.00
Sale value
$2.43M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Jonathan ZalevskyChief R&D Officer
4
Filed Aug 20, 2026Period of report Aug 18, 20260001193125-26-359588
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF1F2186$71.98$13.39K9,570Direct
Filing footnotes · 2
  1. F1Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  2. F2This transaction was executed in multiple trades at prices ranging from $71.78 to $72.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Howard W RobinDirector · President & CEO
4
Filed Aug 20, 2026Period of report Aug 18, 20260001193125-26-359586
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 18, 2026
Common StockF1F2418$71.98$30.09K54,627Direct
Filing footnotes · 2
  1. F1Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  2. F2This transaction was executed in multiple trades at prices ranging from $71.78 to $72.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Jonathan ZalevskyChief R&D Officer
4Rule 10b5-1 plan disclosed
Filed Jul 2, 2026Period of report Jun 30, 20260001193125-26-295112
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 30, 2026
Common StockF15,681$70.00$397.67K9,756Direct
Filing footnotes · 1
  1. F1This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.
Open on SEC EDGAR
Howard W RobinDirector · President & CEO
4Rule 10b5-1 plan disclosed
Filed Jun 18, 2026Period of report Jun 16, 20260001193125-26-276236
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 17, 2026
Common StockF1F45,500$60.81$334.46K59,545Direct
SaleJun 17, 2026
Common StockF1F54,500$61.65$277.43K55,045Direct
SaleJun 16, 2026
Common StockF1F25,303$59.97$318.02K69,742Direct
SaleJun 16, 2026
Common StockF1F34,697$60.71$285.15K65,045Direct
Filing footnotes · 5
  1. F1This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.
  2. F2This transaction was executed in multiple trades at prices ranging from $59.35 to $60.33 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
  3. F3This transaction was executed in multiple trades at prices ranging from $60.37 to $61.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
  4. F4This transaction was executed in multiple trades at prices ranging from $60.22 to $61.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
  5. F5This transaction was executed in multiple trades at prices ranging from $61.22 to $62.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Jonathan ZalevskyChief R&D Officer
4Rule 10b5-1 plan disclosed
Filed Jun 17, 2026Period of report Jun 15, 20260001193125-26-274534
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 15, 2026
Common StockF1F25,538$60.71$336.21K15,437Direct
Filing footnotes · 2
  1. F1This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.
  2. F2This transaction was executed in multiple trades at prices ranging from $60.06 to $61.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Jonathan ZalevskyChief R&D Officer
4
Filed May 21, 2026Period of report May 19, 20260001193125-26-235030
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 19, 2026
Common StockF1F2199$65.51$13.04K20,975Direct
Filing footnotes · 2
  1. F1Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  2. F2This transaction was executed in multiple trades at prices ranging from $64.88 to $68.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Howard W RobinDirector · President & CEO
4
Filed May 21, 2026Period of report May 19, 20260001193125-26-235027
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 19, 2026
Common StockF1F2444$65.51$29.09K75,045Direct
Filing footnotes · 2
  1. F1Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  2. F2This transaction was executed in multiple trades at prices ranging from $64.88 to $68.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Jonathan ZalevskyChief R&D Officer
4
Filed Feb 20, 2026Period of report Feb 18, 20260001193125-26-061886
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF1F2180$73.00$13.14K21,174Direct
Filing footnotes · 2
  1. F1Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  2. F2This transaction was executed in multiple trades at prices ranging from $72.51 to $74.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Howard W RobinDirector · President & CEO
4
Filed Feb 20, 2026Period of report Feb 18, 20260001193125-26-061885
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF1F2423$73.00$30.88K75,489Direct
Filing footnotes · 2
  1. F1Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  2. F2This transaction was executed in multiple trades at prices ranging from $72.51 to $74.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Jonathan ZalevskyChief R&D Officer
4Rule 10b5-1 plan disclosed
Filed Jan 22, 2026Period of report Jan 20, 20260001193125-26-019843
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 20, 2026
Common StockF1F23,867$35.67$137.94K21,354Direct
Filing footnotes · 2
  1. F1This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.
  2. F2This transaction was executed in multiple trades at prices ranging from $35.17 to $36.23 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Open on SEC EDGAR
Jonathan ZalevskyChief R&D Officer
4
Filed Nov 25, 2025Period of report Nov 21, 20250001193125-25-297855
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 25, 2025
Common StockF3F41,157$54.28$62.80K18,971Direct
Filing footnotes · 6
  1. F1Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on December 18, 2020 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.
  2. F2The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 20, 2025 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on November 21, 2025.
  3. F3Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  4. F4This transaction was executed in multiple trades at prices ranging from $58.26 to $59.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
  5. F5These stock options were granted on December 18, 2020 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of four years from the date of grant.
  6. F6The Compensation Committee determined on November 20, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on November 21, 2025.
Open on SEC EDGAR
Mark Andrew WilsonChief Legal Officer
4
Filed Nov 25, 2025Period of report Nov 21, 20250001193125-25-297852
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 25, 2025
Common StockF4F5F3630$54.28$34.20K21,585Direct
Filing footnotes · 7
  1. F1Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on December 18, 2020 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.
  2. F2The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 20, 2025 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on November 21, 2025.
  3. F3This number includes 508 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).
  4. F4Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  5. F5This transaction was executed in multiple trades at prices ranging from $58.26 to $59.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
  6. F6These stock options were granted on December 18, 2020 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of four years from the date of grant.
  7. F7The Compensation Committee determined on November 20, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on November 21, 2025.
Open on SEC EDGAR
Howard W RobinDirector · President & CEO
4
Filed Nov 25, 2025Period of report Nov 21, 20250001193125-25-297850
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 25, 2025
Common StockF3F42,207$54.28$119.80K54,245Direct
Filing footnotes · 6
  1. F1Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on December 18, 2020 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the "2017 Plan") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three years from the date of grant.
  2. F2The Organization and Compensation Committee of the Board of Directors of the Issuer ("Compensation Committee") determined on November 20, 2025 that the performance-based vesting requirement for these RSUs was satisfied and these RSUs vested on November 21, 2025.
  3. F3Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  4. F4This transaction was executed in multiple trades at prices ranging from $58.26 to $59.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
  5. F5These stock options were granted on December 18, 2020 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of four years from the date of grant.
  6. F6The Compensation Committee determined on November 20, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on November 21, 2025.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.